Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AA Alcoa	Target Raised by	B. Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nick Giles Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.58 -3.2%	$38.00 ➝ $40.00	Buy
AARD Aardvark Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.44 +1.9%	$40.00	Buy
ACDVF Air Canada	Downgraded by	National Bankshares Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.42 -2.6%		Outperform ➝ Sector Perform
ACN Accenture	Target Lowered by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$235.20 -2.0%	$290.00 ➝ $285.00	Outperform
ACTU Actuate Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.88 -3.0%	$20.00	Buy
ADVM Adverum Biotechnologies	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Caufield Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.06 +17.3%	$30.00	Buy
AFRM Affirm	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel R. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$82.73 -8.2%		Sector Perform
AGCO AGCO	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kyle Menges Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$109.61 +0.1%	$125.00 ➝ $120.00	Neutral
AIOT PowerFleet	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gary Prestopino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.57 +3.3%	$15.00	Outperform
ALLY Ally Financial	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Pancari Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.62 -2.0%	$42.00 ➝ $45.00	In-Line

ALV Autoliv	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijay Rakesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$126.66 +0.6%	$130.00 ➝ $140.00	Outperform
ALVO Alvotech	Upgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Niall Alexander Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.70 +8.6%	$14.00	Hold ➝ Buy
AMAT Applied Materials	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Barger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$200.87 +0.2%	$200.00 ➝ $220.00	Overweight
AMG Affiliated Managers Group	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexander Paris Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$241.49 -1.0%	$240.00	Outperform
ANIK Anika Therapeutics	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Petusky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.12 -2.4%	$15.00	Outperform
ANP Anpario	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 502 +3.0%
APEI American Public Education	Target Raised by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexander Paris Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$36.93 +1.3%	$36.00 ➝ $40.00	Outperform
APP AppLovin	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Martin Yang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$651.18 +1.2%	$500.00 ➝ $740.00	Outperform
AR Antero Resources	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Diamond Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.36 +2.4%	$37.00 ➝ $39.00	Neutral ➝ Buy
ARE Alexandria Real Estate Equities	Initiated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$87.00 +1.3%	$100.00	Market Perform ➝ Outperform
ASO Academy Sports and Outdoors	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Greg Melich Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$47.75 +3.2%	$55.00 ➝ $50.00	In-Line
ASUR Asure Software	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vincent Colicchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.10 +0.1%	$15.00	Outperform
ATGE Adtalem Global Education	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexander Paris Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$143.88 +0.4%	$150.00	Outperform
ATZ Aritzia	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$87.43 -2.4%	C$92.00 ➝ C$100.00
AX Axos Financial	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Tamayo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$88.25 +0.3%	$95.00 ➝ $100.00	Outperform
AXON Axon Enterprise	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$777.58 +0.2%		Overweight
BAC Bank of America	Target Lowered by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Kotowski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$51.68 -0.5%	$57.00 ➝ $56.00	Outperform
BC Brunswick	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Boss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$62.56 -1.8%	$63.00 ➝ $70.00	Neutral
BDI Black Diamond Group	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$14.09 +4.3%	C$15.00 ➝ C$17.00
BDI Black Diamond Group	Target Raised by	Acumen Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$14.09 +4.3%	C$14.50 ➝ C$17.00	Buy
BDIMF Black Diamond Group	Reiterated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$10.14 +5.2%		Outperform
BE Bloom Energy	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Julien Dumoulin-Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$77.42 -10.3%	$21.00 ➝ $24.00	Underperform
BEEP Mobile Infrastructure	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Steinke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.65 +2.0%	$6.50	Outperform
BRBY Burberry Group	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,143 +1.9%	GBX 580 ➝ GBX 680	Underperform
BSX Boston Scientific	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Marie Thibault Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$97.63 +0.6%	$127.00	Buy
C Citigroup	Target Lowered by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Kotowski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$103.01 -0.5%	$124.00 ➝ $123.00	Outperform
CARR Carrier Global	Target Lowered by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$59.72 -1.0%	$73.00 ➝ $70.00	Hold
CARR Carr's Group	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 148 -0.7%		Hold
CAT Caterpillar	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kyle Menges Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$471.77 -0.1%		Buy
CC Chemours	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Roberts Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.52 -3.0%	$16.00 ➝ $19.00	Outperform

CCCC C4 Therapeutics	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derek Archila Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.59 -0.8%	$5.00 ➝ $10.00	Overweight
CCL Carnival	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Wieczynski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$30.71 0.0%	$34.00 ➝ $38.00	Buy
CDNA CareDx	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Massaro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.57 +3.9%	$22.00	Buy
CIEN Ciena	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ruben Roy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$139.58 +0.2%	$120.00 ➝ $152.00	Buy
CMI Cummins	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kyle Menges Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$423.78 -0.3%	$425.00 ➝ $485.00	Buy
CNK Cinemark	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Sholl Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.96 +3.4%	$36.00	Outperform
CNR Canadian National Railway	Target Lowered by	CIBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$127.52 +0.3%	C$148.00 ➝ C$140.00	Neutral
CNXC Concentrix	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Luke Morison Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.09 -0.8%	$80.00	Buy
COLD Americold Realty Trust	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Mueller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.64 -1.4%	$17.00 ➝ $15.00	Neutral ➝ Underweight
CRAI Charles River Associates	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Steinke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$207.86 -0.3%	$235.00	Outperform
CRR.UN Crombie Real Estate Investment Trust	Target Raised by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$15.03 +0.4%	C$17.00 ➝ C$17.50	Strong-Buy
CRSP CRISPR Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$60.76 -2.2%	$80.00	Buy
CRWD CrowdStrike	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$484.10 -1.8%		Outperform
CRWD CrowdStrike	Target Raised by	JMP Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Trevor Walsh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$484.10 -1.8%	$500.00 ➝ $550.00	Market Outperform
CRWV CoreWeave	Target Set by	Melius Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Reitzes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$130.89 -1.8%	$128.00 ➝ $165.00	Hold ➝ Buy
CRWV CoreWeave	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Turrin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$130.89 -1.8%	$105.00 ➝ $170.00	Equal Weight ➝ Overweight
CRWV CoreWeave	Upgraded by	Melius Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$130.89 -1.8%	$165.00	Hold ➝ Buy
CTOR Citius Oncology	Upgraded by	Maxim Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Okunewitch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.81 +1.7%	$6.00	Hold ➝ Buy
CTOR Citius Oncology	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1.81 +1.7%		Hold ➝ Buy
CUBI Customers Bancorp	Target Raised by	B. Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Hal Goetsch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$66.33 -0.4%	$85.00 ➝ $86.00	Buy
CURI CuriosityStream	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Sholl Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.11 -1.0%	$6.00	Outperform
CVNA Carvana	Reiterated by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeff Lick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$378.33 -3.2%	$440.00	Overweight
CXT Crane NXT	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Summerville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$64.80 +14.7%	$85.00	Buy
CYBR CyberArk Software	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Trevor Walsh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$481.69 -1.9%		Market Outperform ➝ Market Perform
DG Dollar General	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Montani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$103.68 +1.8%	$118.00 ➝ $114.00	In-Line
DIS Walt Disney	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laura Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$112.21 -0.3%	$125.00	Buy
DKS DICK'S Sporting Goods	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kate McShane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$228.77 +4.3%	$274.00	Buy
DLTR Dollar Tree	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Greg Melich Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.65 +0.2%	$108.00 ➝ $105.00	In-Line
DRD DRDGOLD	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.52 +3.7%	$18.75 ➝ $30.50	Buy
ENPH Enphase Energy	Target Raised by	Glj Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gordon Johnson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.36 -7.8%	$19.80 ➝ $23.49	Sell
EQT EQT	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$50.99 +2.0%	$60.00 ➝ $63.00	Buy
FITB Fifth Third Bancorp	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Horowitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.14 +0.4%	$47.00 ➝ $50.00	Neutral
FND Floor & Decor	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Greg Melich Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$81.90 +1.1%	$90.00 ➝ $85.00	In-Line
FNV Franco-Nevada	Target Raised by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian MacArthur Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$213.56 -0.3%	$203.00 ➝ $218.00	Outperform
FNX Fonix Mobile	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 215 -1.8%	GBX 293	Buy
GLW Corning	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Spector Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$81.00 +2.3%	$91.00	Buy
GM General Motors	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijay Rakesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$58.60 -0.5%	$58.00 ➝ $67.00	Outperform
GMAB Genmab A/S	Upgraded by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Schmidt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.73 +0.5%	$43.00	Neutral ➝ Buy
GSHD Goosehead Insurance	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Hughes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$77.37 -2.5%	$90.00 ➝ $85.00	Hold
GSY goeasy	Target Set by	National Bankshares Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$174.66 -5.2%	C$265.00	Outperform
GSY goeasy	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$174.66 -5.2%	C$235.00 ➝ C$225.00	Sector Perform
GTN Gray Media	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Sholl Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.83 +5.0%	$6.50	Outperform
HAE Haemonetics	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Petusky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$50.61 -1.1%	$86.00	Outperform
HESM Hess Midstream Partners	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Douglas Irwin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.90 -0.7%	$41.00 ➝ $37.00	Neutral
HNGE Hinge Health	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Craig Hettenbach Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$59.70 +3.2%	$57.00 ➝ $67.00	Overweight
HOOD Robinhood Markets	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Allen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$126.20 +1.0%	$120.00 ➝ $135.00	Neutral
HOOD Robinhood Markets	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Moley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$126.20 +1.0%	$120.00 ➝ $140.00	Overweight
HOUS Anywhere Real Estate	Upgraded by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Bouley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.44 +1.4%	$3.50 ➝ $11.00	Underweight ➝ Equal Weight
HOUS Anywhere Real Estate	Target Set by	Compass Point Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Bouley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.44 +1.4%	$11.00
HRB H&R Block	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexander Paris Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.80 -0.7%	$62.00	Outperform

HROW Harrow	Target Raised by	B. Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mayank Mamtani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$48.85 +6.0%	$65.00 ➝ $70.00	Buy
HROW Harrow	Target Raised by	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chase Knickerbocker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$48.85 +6.0%	$54.00 ➝ $64.00	Buy
HSIC Henry Schein	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Petusky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$69.21 +1.9%	$78.00	Outperform
ICFI ICF International	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Steinke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.13 -1.9%	$107.00	Outperform
INTU Intuit	Target Raised by	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$699.18 -0.4%	$560.00 ➝ $670.00	Neutral
IONS Ionis Pharmaceuticals	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gena Wang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$62.57 +2.0%	$78.00 ➝ $82.00	Overweight
IONS Ionis Pharmaceuticals	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Ulz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$62.57 +2.0%	$71.00 ➝ $86.00	Overweight
IONS Ionis Pharmaceuticals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$62.57 +2.0%	$95.00	Buy
IONS Ionis Pharmaceuticals	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Gerberry Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$62.57 +2.0%	$81.00 ➝ $83.00	Buy
IONS Ionis Pharmaceuticals	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Debjit Chattopadhyay Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$62.57 +2.0%	$90.00 ➝ $92.00	Buy
IRTC iRhythm Technologies	Initiated by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijay Kumar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$175.46 -5.0%	$185.00	In-Line
JNJ Johnson & Johnson	Upgraded by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vamil Divan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$176.35 +1.2%	$167.00 ➝ $206.00	Neutral ➝ Buy
KAI Kadant	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gary Prestopino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$304.91 -0.7%	$380.00	Outperform
KELYA Kelly Services	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Steinke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.44 -2.1%	$25.00	Outperform
KOO Kooth	Target Raised by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 141.80 -5.5%	GBX 260 ➝ GBX 300	Buy
KOO Kooth	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 141.80 -5.5%	GBX 490 ➝ GBX 430	Buy
KVUE Kenvue	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Javier Escalante Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.26 +1.7%	$23.00 ➝ $18.00	In-Line
KVUE Kenvue	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Filippo Falorni Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.26 +1.7%		Neutral
LEN Lennar	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$123.13 +1.0%	$122.00 ➝ $126.00	Neutral
LII Lennox International	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Damian Karas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$529.94 -0.7%	$676.00 ➝ $610.00	Neutral
LINC Lincoln Educational Services	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexander Paris Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.67 -0.7%	$25.00	Outperform
LINE Lineage	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Mueller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.98 -3.5%	$44.00 ➝ $43.00	Underweight
LMAT LeMaitre Vascular	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Petusky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$89.87 -2.6%	$95.00	Outperform
LOPE Grand Canyon Education	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexander Paris Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$212.63 +0.3%	$230.00	Outperform
LPL LG Display	Upgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jimmy Yoon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.93 -0.5%		Sell ➝ Neutral
LRN Stride	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexander Paris Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$142.25 -1.3%	$185.00	Outperform
LULU lululemon athletica	Reiterated by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Altschwager Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$173.33 0.0%	$225.00 ➝ $195.00	Outperform ➝ Neutral
LYB LyondellBasell Industries	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Richardson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$50.39 -1.4%	$90.00 ➝ $65.00	In-Line
MAB1 Mortgage Advice Bureau	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 734 +7.9%	GBX 1,150	Buy
MAMA Mama's Creations	Initiated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Holland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.60 -3.2%	$18.00	Buy
MAU Montage Gold	Target Raised by	Beacon Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$3.70 +1.6%	C$6.00 ➝ C$7.80	Buy
MCS Marcus	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Sholl Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.57 +0.6%	$25.00	Outperform
MMSI Merit Medical Systems	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Petusky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$83.72 +0.2%	$103.00	Outperform
MNPR Monopar Therapeutics	Initiated by	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chad Messer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$67.67 +6.3%	$106.00	Buy
MPLX Mplx	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Blum Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$50.06 +0.0%	$60.00 ➝ $59.00	Overweight
MSI Motorola Solutions	Target Set by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Fish Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$470.07 -0.3%	$495.00	Neutral
NEM Newmont	Target Raised by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian MacArthur Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$84.59 +1.0%	$77.00 ➝ $84.00	Outperform
NIO NIO	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijay Rakesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.94 +0.4%	$6.00 ➝ $7.00	Neutral
NIO NIO	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$6.94 +0.4%	$8.10 ➝ $8.60	Buy
NKE NIKE	Target Raised by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Cristina Fernandez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$70.92 -0.5%	$70.00 ➝ $75.00	Market Perform
NKE NIKE	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alex Straton Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$70.92 -0.5%	$64.00 ➝ $70.00	Equal Weight
NKTR Nektar Therapeutics	Target Raised by	B. Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mayank Mamtani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$59.60 +1.2%	$85.00 ➝ $105.00	Buy
NVDA NVIDIA	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Cassidy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$178.43 -2.8%	$215.00	Buy
NVDA NVIDIA	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Lipacis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$178.43 -2.8%	$214.00 ➝ $225.00	Outperform
NVDA NVIDIA	Target Raised by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$178.43 -2.8%	$220.00 ➝ $230.00
NVDA NVIDIA	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Timothy Arcuri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$178.43 -2.8%		Buy
NVDA NVIDIA	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stacy Rasgon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$178.43 -2.8%		Buy
ODD ODDITY Tech	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Boone Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$61.06 +0.3%	$80.00	Market Outperform
ODP ODP	Downgraded by	Noble Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$27.86 +0.7%		Market Perform
OFIX Orthofix Medical	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Petusky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.75 -0.7%	$17.00	Outperform

OKYO OKYO Pharma	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.20 -2.2%	$7.00	Buy
OMC Omnicom Group	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Cahall Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$76.27 +2.3%	$78.00 ➝ $91.00	Equal Weight ➝ Overweight
ONTO Onto Innovation	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Blayne Curtis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$136.58 +5.0%	$100.00 ➝ $170.00	Hold ➝ Buy
OPCH Option Care Health	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Petusky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.70 -3.4%	$38.00	Outperform
ORCL Oracle	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Weiss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$314.90 -4.0%	$246.00 ➝ $320.00	Equal Weight
OSK Oshkosh	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kyle Menges Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$131.35 -0.9%	$150.00 ➝ $160.00	Buy
OUT OUTFRONT Media	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Sholl Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.81 +0.0%	$21.00	Outperform
PAL Proficient Auto Logistics	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexander Paris Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.92 -1.1%	$12.00	Outperform
PARR Par Pacific	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manav Gupta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.13 +5.4%	$23.00 ➝ $37.00	Neutral
PBF PBF Energy	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manav Gupta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.74 +3.6%	$28.00 ➝ $37.00	Buy
PDFS PDF Solutions	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Diffely Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.96 +15.2%	$24.00	Buy
PETS Pets at Home Group	Target Lowered by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 202.26 +1.9%	GBX 330 ➝ GBX 250	Buy
PINC Premier	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Close Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.95 -1.1%	$25.00 ➝ $28.25	Hold
PLTR Palantir Technologies	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mariana Perez Mora Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$182.55 +1.8%	$180.00 ➝ $215.00	Buy
PNC The PNC Financial Services Group	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Horowitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$203.95 +0.4%	$217.00 ➝ $230.00	Buy
PNC The PNC Financial Services Group	Target Lowered by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Kotowski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$203.95 +0.4%	$238.00 ➝ $235.00	Outperform
POU Paramount Resources	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$21.81 +0.8%	C$23.00 ➝ C$26.00	Sector Perform
POWI Power Integrations	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Williams Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.54 -3.5%	$55.00	Buy
PPTA Perpetua Resources	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.95 +0.5%	$30.00	Buy
PRDO Perdoceo Education	Target Raised by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexander Paris Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.68 -0.6%	$40.00 ➝ $42.00	Outperform
PRI Primerica	Upgraded by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jack Matten Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$285.24 +4.8%	$292.00 ➝ $318.00	Market Perform ➝ Outperform
PRLD Prelude Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.03 +2.0%	$5.00	Buy
PRMRF Paramount Resources	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$15.75 +0.6%		Sector Perform
PRO PROS	Downgraded by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$22.86 -0.7%		Overweight ➝ Sector Weight
PRO PROS	Downgraded by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Berg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.86 -0.7%	$25.00	Buy ➝ Hold
PROC ProCook Group	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 33 +0.3%	GBX 48 ➝ GBX 54	Buy
PTLO Portillo's	Reiterated by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jim Salera Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.29 -3.1%	$10.00	Equal Weight
RDDT Reddit	Reiterated by	Cannonball Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$237.28 -7.9%		Buy
RF Regions Financial	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Horowitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.72 +0.6%	$30.00 ➝ $32.00	Buy
RIVN Rivian Automotive	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijay Rakesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.53 +1.9%	$12.00 ➝ $14.00	Neutral
RRC Range Resources	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Diamond Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.74 +2.3%	$40.00 ➝ $39.00	Neutral
SATS EchoStar	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Rollins Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.64 +0.7%	$67.00 ➝ $85.00	Neutral
SBRY J Sainsbury	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 325.20 +1.2%
SILA Sila Realty Trust	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Kilichowski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.36 -1.0%	$27.00	Equal Weight
SMLR Semler Scientific	Target Lowered by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Palmer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$32.66 +1.9%	$101.00 ➝ $86.00	Buy
SNA Snap-On	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gary Prestopino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$339.49 +0.6%	$350.00	Outperform
SNWS Smiths News	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 60 +1.7%	GBX 95	Buy
SNX TD SYNNEX	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vincent Colicchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$151.67 +0.1%	$156.00	Outperform
SRRK Scholar Rock	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.75 +3.6%	$50.00 ➝ $44.00	Buy
SSTY Safestay	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 21.80 -3.1%
STZ Constellation Brands	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Filippo Falorni Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$131.64 -1.4%	$155.00 ➝ $145.00	Neutral
SUPR Supermarket Income REIT	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 77.80 -0.6%	GBX 73	Hold
SYM Symbotic	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Damian Karas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$54.22 -10.7%	$27.00 ➝ $35.00	Neutral ➝ Sell
SYS1 System1 Group	Downgraded by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 262 -34.5%	GBX 865 ➝ GBX 550	Speculative Buy
TEAM Atlassian	Initiated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Koji Ikeda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$165.68 -2.9%	$200.00	Neutral
TEX Terex	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kyle Menges Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$51.86 -0.2%	$55.00 ➝ $58.00	Neutral
TGT Target	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Greg Melich Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$87.02 +0.5%	$106.00 ➝ $105.00	In-Line
TKR Timken	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kyle Menges Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$76.74 -0.1%	$85.00 ➝ $90.00	Buy
TLX Telix Pharmaceuticals	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laura Sutcliffe Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.93 +8.8%	$23.00 ➝ $20.00	Buy
TMG The Mission Group	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 24.90 +8.3%	GBX 55	Buy

TSLA Tesla	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijay Rakesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$425.85 -1.9%	$375.00 ➝ $450.00	Outperform
TTE TotalEnergies	Downgraded by	BNP Paribas Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$61.55 +1.3%		Outperform ➝ Neutral
TTE TotalEnergies	Reiterated by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$61.55 +1.3%		Outperform ➝ Neutral
TTMI TTM Technologies	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Ricchiuti Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.54 +4.2%	$56.00 ➝ $65.00	Buy
UPWK Upwork	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kunal Madhukar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.66 +1.7%	$16.00 ➝ $21.00	Neutral
URC Uranium Royalty	Downgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$6.18 -2.1%	C$4.50 ➝ C$5.00	Outperform ➝ Market Perform
URG Ur Energy	Target Raised by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Reagor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.68 -1.8%	$1.60 ➝ $1.80	Buy
URI United Rentals	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kyle Menges Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$955.71 +1.3%	$1,000.00 ➝ $1,080.00	Buy
URI United Rentals	Target Set by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chad Dillard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$955.71 +1.3%	$1,128.00	Market Perform ➝ Outperform
UROY Uranium Royalty	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.48 -2.0%		Outperform ➝ Market Perform
USB U.S. Bancorp	Target Lowered by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Kotowski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.34 -0.3%	$67.00 ➝ $66.00	Outperform
WELL Welltower	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Austin Wurschmidt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$172.56 +3.1%	$150.00 ➝ $200.00	Overweight
WEN Wendy's	Reiterated by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Staszak Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.09 -2.4%		Buy ➝ Hold
WFC Wells Fargo & Company	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$84.33 -1.0%		Neutral
WIX Wix.com	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$177.93 -3.4%		Outperform
WIX Wix.com	Target Raised by	JMP Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Boone Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$177.93 -3.4%	$200.00 ➝ $210.00	Market Outperform
WSO Watsco	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Damian Karas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$395.30 +1.0%	$450.00 ➝ $425.00	Neutral
XYZ Block	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Vafi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$76.44 -1.3%	$80.00	Buy
ZDC Zedcor	Target Set by	National Bankshares Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$4.69 +5.9%	C$5.50	Outperform
ZGN Ermenegildo Zegna	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daria Nasledysheva Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.57 +1.3%	$9.50 ➝ $10.00	Buy
ZSPC zSpace	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexander Paris Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.64 +5.1%	$5.00	Outperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 07:10 PM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

July 5, 2023

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings